Carbapenem resistance is a significant public health concern as it limits treatment options for infections caused by Gram-negative bacteria, including those that lead to severe illness and mortality. This resistance arises through various mechanisms, such as the production of carbapenemase enzymes, efflux pumps, and porin loss, making infections difficult to treat and control.